By: Lawrence Bachorik, Ph.D. It’s always a good feeling when an outside organization recognizes an FDA employee for excellent performance in pursuit of our agency’s public health mission. Recently, this was done by the Parenteral Drug Association (PDA) when it … Continue reading →
The U.S. Food and Drug Administration (FDA) is informing the public about the results of a large, combined analysis (called a meta-analysis) of clinical trials that compared patients who received the smoking cessation drug Chantix (varenicline) to patients who received a placebo (an inactive treatment).
